Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease - Top-Institutions - MDSpire

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease

  • By

  • Erica Buoso

  • Mirco Masi

  • Roberta Valeria Limosani

  • Francesca Fagiani

  • Chiara Oliviero

  • Giorgia Colombo

  • Luigi Cari

  • Marco Gentili

  • Eleonora Lusenti

  • Lucrezia Rosati

  • Federica Pisati

  • Alessandra Pasini

  • Marco Vincenzo Lenti

  • Antonio Di Sabatino

  • Claire Louise Mobbs

  • Stefan Przyborski

  • Simona Ronchetti

  • Cristina Travelli

  • Marco Racchi

  • December 18, 2024

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Molecular Biology

  • #2

    Mount Sinai Hospital - Icahn School of Medicine
    Mount Sinai Hospital - Icahn School of Medicine

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammation Biology
    • Translational Medicine

  • #3

    University of California, San Diego (UCSD) Health
    University of California, San Diego (UCSD) Health

    San Diego, CA

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Cell Signaling

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Molecular Medicine
    • Inflammatory Diseases

  • #5

    Massachusetts General Hospital (MGH) - Harvard Medical School
    Massachusetts General Hospital (MGH) - Harvard Medical School

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Translational Research

Original Source(s)

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease

  • by Erica Buoso, Mirco Masi, Roberta Valeria Limosani, Francesca Fagiani, Chiara Oliviero, Giorgia Colombo, Luigi Cari, Marco Gentili, Eleonora Lusenti, Lucrezia Rosati, Federica Pisati, Alessandra Pasini, Marco Vincenzo Lenti, Antonio Di Sabatino, Claire Louise Mobbs, Stefan Przyborski, Simona Ronchetti, Cristina Travelli, Marco Racchi

  • December 18, 2024

Related Content

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min
Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

The Impact of Metabolic Bariatric Surgery on Inflammatory Bowel Disease Risk and Outcomes in Adults With Obesity: a Propensity-matched, Nationwide, Analysis